A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents

Cancer Nursing

Volumn 32, Issue 6, 2009, Pages

  Decker, Veronica ^a   Spoelstra, Sandra ^b   Miezo, Emily ^b   Bremer, Renee ^b   You, Mei ^b   Given, Charles ^b   Given, Barbara ^b  

^a Cancer Care Associates   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Adherence; Automated Voice; Oral agents; Response

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; ERLOTINIB; LAPATINIB; METHOTREXATE;

ADULT; AGED; ANOREXIA; ARTICLE; AUTOMATIC SPEECH RECOGNITION; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; COLON CANCER; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG MONITORING; DYSPNEA; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; LUNG CANCER; MALE; MOUTH PAIN; NAUSEA; NURSING INTERVENTION; PAIN; PARESTHESIA; PATIENT COMPLIANCE; PATIENT SATISFACTION; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; RASH; SKIN TINGLING; SLEEP DISORDER; SOLID TUMOR; SWELLING; SYMPTOM; TREATMENT REFUSAL; UNITED STATES; VOMITING;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; AUTOMATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; MONITORING, PHYSIOLOGIC; NEOPLASMS; NURSING RESEARCH; ONCOLOGIC NURSING; PATIENT COMPLIANCE; PATIENT SATISFACTION; PILOT PROJECTS; QUESTIONNAIRES; REMINDER SYSTEMS; TELEPHONE;

EID: 73649147382     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/NCC.0b013e3181b31114     Document Type: Article

References (39)

1. Miakowski C, Shockney L, Chelebowski T. Adherence to oral endocrine therapy for breast cancer: a nursing perspective. Clin J Oncol Nurs. 2008; 12(2):213-221.
2. Moore S, Stoker Y. Promoting patient adherence to oral cancer treatment. Oncol Nurs Forum. 2008;35:501.
3. Weingart S, Bach P, Johnson S, et al. NCCN Task Force Report: oral chemotherapy. J Natl Compr Canc Netw. 2008;6:S-1-S-17.
4. Bedell C. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs. 2003;7(suppl 6):5-9.
5. Hollywood E, Semple D. Nursing strategies for patients on oral chemotherapy. Oncology (Huntingt). 2001;15(1 suppl 2):37-39.
6. Partridge A, Avorn J, Wang P, Winer E. Adherence to therapy with oral antineoplastic agents. J Natl Canc Inst. 2002;94(9):652-661.
7. Sharma S, Saltz L. Oral chemotheraputic agents for colorectal cancer. Oncologist. 2000;5:99-107.
8. Blasdel C, Bubalo J. Adherence to oral cancer therapies: meeting the challenge of new patient care needs. Clinical Oncology Special Reports, April 2006.
9. Shea C. Improving Medication Adherence: How to Talk With Patients About Their Medications. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
10. Kirk M, Hudis C. Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clin Breast Cancer. 2008; 8(2):155-161.
11. Partridge A, LaFountain A, Mayer E, Taylor B, Winer E, Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008;26:556-562.
12. DiMatteoM, Giordani P, Lepper H, CroghanT. Patient adherence andmedical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811.
13. Jeon S, Given C, Sikorski A, Given B. Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? J Pain Symptom Manage. 2009;37(2):220-232.
14. Given B, Given C, Sikorskii A, et al. Establishing mild, moderate, and severe scores for cancer related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? J Pain Symptom Manage. 2008;35(2):126-135.
15. Speer J, Hillenberg B, Sugrue D, et al. Estrogen replacement therapy in breast cancer survivors: a matched-controlled series. Menopause. 2003;10(4): 277-285.
16. Northouse L, Mood D, Kershaw T, et al. Quality of Life of women with recurrent breast cancer and their family members. J Clin Oncol. 2002; 20(19):4050-4064.
17. Given C, Given B, Rahbar M, et al. Does a symptom management intervention affect depression among cancer patients: results from a clinical trial. Psychooncology. 2004;13(11):818-830.
18. Wyatt G, Kurtz M, Friedman L, Given B, Given C. Preliminary testing of the long-term quality of life instrument for female cancer survivors. J Nurs Meas. 1996;4(2):153-170. (Pubitemid 126432656)
19. Given B, Given C, McCorkle R, et al. Pain and fatigue management: results of a nursing randomized clinical trial. Oncol Nurs Forum. 2002; 29(6):949-956.
20. Given C, Sikorski A, Tamkus D, et al. Managing symptoms among patients with breast cancer during chemotherapy: results of a two-arm behavioral trial. J Clin Oncol. 2008;26(36):5855-5862.
21. Sikorskii A, Given C, Given B, et al. Symptom management for cancer patients: a trial comparing two multimodal interventions. J Pain Symptom Manage. 2007;34(3):253-264.
22. Becker M, Maiman L, Kirscht J, Haefner D, Drachman R. The health belief model and prediction of dietary compliance: a field experiment. J Health Soc Behav. 1977;18:348-365.
23. Given B, Given C, Sikorskii A. Deconstruction of a nursing intervention to examine the mechanism of action. Oncol Nurs Forum. 2007;34:199.
24. Given B, Given C, Jeon S, Sikorskii A. Effect of neutropenia on the impact of a cognitive-behavioral intervention for symptom management. Cancer. 2005;104(4):869-878.
25. Given C, Given B, Rahbar M, et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol. 2004;22(3):507-516.
26. Giesler R, Given B, Given C, et al. Improving the quality of life of patients with prostate carcinoma: a randomized trial testing the efficacy of a nurse-driven intervention. Cancer. 2005;104(4):752-762.
27. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401.
28. Rawl S, Given B, Given C, et al. Intervention to improve psychological functioning for newly diagnosed patients with cancer. Oncol Nurs Forum. 2002;29(6):967-975.
29. Escalada P, Griffiths P. Do people with cancer comply with oral chemotherapy treatments? Brit J Commun Nurs. 2007;11(12):532-536.
30. Garber M, Nau D, Erickson S, Aikens J, Lawrence J. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7):649-652.
31. Schlenk E, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs. 2004;30(7):33-43.
32. Gollwitzer P. Implementation intentions: strong effects of simple plans. Am Psychol Assoc. 1999;54(7):493-503.
33. Nilsson K, Andersson K, Bergkvist A, Bjorkman I, Brismar A, Moen J. Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients. Eur J Cancer Care. 2006;15(3):235-237.
34. Friedman R, Kazis L, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9(4): 285-292.
35. Schectman G, Hiatt J, Hartz A. Telephone contacts do not improve adherence to niacin or bile acid sequestrant therapy. Ann Pharmacother. 1994;28(1):29-34.
36. Burke L, Dunbar-Jacob J, Orchard T, Sereika S. Improving adherence to a cholesterol-lowering diet: a behavioral intervention study. Patient Educ Couns. 2005;57(1):134-142.
37. Kim H, Oh J. Adherence to diabetes control recommendations: impact of nurse telephone calls. J Adv Nurs. 2003;44(3):256-261.
38. Haynes R, McDonald H, Garg A. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880-2883.
39. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540Y550.